# Mey Capital Matrix

> Mey Capital Matrix is a VC fund in München backing Health Care, Medical and Biotechnology. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: München, Germany
- Total investments: 4
- Last investment: May 2023
- Lead investor: 25%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/mey-capital-matrix-gmbh/
- Website: http://www.meycapital.com

Mey Capital Matrix is a VC fund in München focused on Health Care and Medical. The MEY Capital Matrix GmbH is a company which helps to reduce healthcare cost and provides personalized medicines.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 75% |
| Medical | 2 | 50% |
| Biotechnology | 2 | 50% |
| Organic Food | 1 | 25% |
| Food and Beverage | 1 | 25% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 25% |
| Series C | 1 | 25% |
| Series D | 1 | 25% |
| Funding Round | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Pumpkin Organics | Pumpkin Organics is an innovative baby food concept that values vegetables and good healthy eating from the very first bite. Our recipes are 100% organic with nothing extra – no added sugars, salt, preservatives or additives. | $4.3M | Seed | May 17, 2023 |  |
| iThera Medical | iThera Medical offers access to innovative technology and know-how in photonic molecular imaging. The company was founded in 2010, as a spin-off from the Helmholtz Zentrum Muenchen, the German Research Center for Environmental Health (HMGU). Together, they pursue the further development of proprietary MSOT technology for use in preclinical andclinical applications. | $14.3M |  | Dec 21, 2022 |  |
| iThera Medical | iThera Medical offers access to innovative technology and know-how in photonic molecular imaging. The company was founded in 2010, as a spin-off from the Helmholtz Zentrum Muenchen, the German Research Center for Environmental Health (HMGU). Together, they pursue the further development of proprietary MSOT technology for use in preclinical andclinical applications. | $13.8M | Series D | Dec 21, 2022 |  |
| GNA Biosolutions | GNA Biosolutions is a molecular technology company based in Martinsried, Germany. Their breakthrough technology, Pulse Controlled Amplification, transforms molecular testing by combining ultrafast nucleic acid amplification with intrinsic sample prep, to enable powerful solutions for the laboratory, on-site applications and the Point of Care. Theirvision is to bring the power of molecular testing, from sample to answer, to everyone, everywhere. | $13.5M | Series C | Aug 06, 2019 |  |

4 of 4 investments shown.

## Co-investors
- [OCCIDENT](https://shizune.co/investors/profile/occident-group) — VC Fund, 3 deals together
- [Wachstumsfonds Bayern](https://shizune.co/investors/profile/wachstumsfonds-bayern) — VC Fund, 3 deals together
- [BayBG Venture Capital](https://shizune.co/investors/profile/baybg) — VC Fund, 2 deals together
- [Falk Strascheg Holding](https://shizune.co/investors/profile/falk-strascheg-holding) — VC Fund, 2 deals together
- [Fluxunit - Osram Ventures](https://shizune.co/investors/profile/fluxunit-osram-ventures) — VC Fund, 2 deals together
- [TRUMPF Venture](https://shizune.co/investors/profile/trumpf-venture) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Blue Horizon Corporation](https://shizune.co/investors/profile/blue-horizon-corporation) — VC Fund
- [CircleUp](https://shizune.co/investors/profile/circleup-growth-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund

## Featured in investor lists
- [Organic Food VC Funds in Germany](https://shizune.co/investors/organic-food-vc-funds-germany)
- [Organic Food VC Funds in Europe](https://shizune.co/investors/organic-food-vc-funds-europe)

## FAQ

### What does Mey Capital Matrix invest in?

Mey Capital Matrix invests primarily in Health Care, Medical and Biotechnology startups, most often at Seed and Series C stage. Most of the 4 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Mey Capital Matrix last invest?

The most recent investment recorded for Mey Capital Matrix closed in May 2023. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co